Published online Dec 31, 2009.
https://doi.org/10.3947/ic.2009.41.6.323
Hemorrhagic Fever with Renal Syndrome
Abstract
Hemorrhagic fever with renal syndrome (HFRS) is an acute febrile illness caused by Eurasian hantaviruses and characterized by renal insufficiency, hemorrhage, thrombocytopenia, and shock. Each hantavirus is primarily associated with a single rodent host species or genus, and is transmitted to human via aerosols of rodent excreta. During the last decades, clinical features of HFRS in Korea have changed with mild degree of hypotension and very low prevalence of oliguria. Treatment of HFRS is mainly supportive. Recently, however, treatment of HFRS patients with ribavirin in China and Korea, within 7 days after the onset of fever, resulted in a reduced mortality as well as shortened course of illness. Although a commercial inactivated Hantaan virus vaccine has been on the market in Korea for more than 15 years, the effect of vaccination is not clear. Further efforts are necessary to develop safer and more effective hantavirus vaccines.
Figure 1
Reported cases of hemorrhagic fever with renal syndrome by year in Korea (Data source: Korea centers for disease control and prevention).
Figure 2
Schematic representation of hantavirus morphology. The single-stranded RNA segments S (small), M (medium), and L (large) are encoded for the nucleocapsid protein, the glycoprotein G1 and G2, and the RNA-dependent RNA polymerase, respectively.
Table 1
Main Natural Reservoirs and Geographic Distribution of Hantaviruses
Table 2
Hantavirus Vaccines Tested in Humans
References
-
Krüger DH, Ulrich R, Lundkvist AA. Hantavirus infections and their prevention. Microbes Infect 2001;3:1129–1144.
-
-
Lee JS. Clinical features of hemorrhagic fever with renal syndrome in Korea. Kidney Int Suppl 1991;35:S88–S93.
-
-
Lee NS, Kim HY, Chae MH, Kim EM, Park SY, Han SH, Kwon OG, Uh Y. The influence of vaccination on the clinical features of hemorrhagic fever with renal syndrome in the last 5 years. Korean J Med 2009;76:459–466.
-
-
Kim HJ, Han SW. Diagnostic challenge of hemorrhagic fever with renal syndrome on admission before its serological confirmation. Korean J Nephrol 2004;23:82–91.
-
-
Lee JK, Hwang SI. Hemorrhagic fever with renal syndrome: Historical aspects. Korean J Med Hist 2004;13:37–61.
-
-
World Health Organization. Bull World Health Organ. 61. 1983. Haemorrhagic fever with renal syndrome: memorandum from a WHO meeting; pp. 269-275.
-
-
Lee HW. Hemorrhagic fever with renal syndrome in Korea. Rev Infect Dis 1989;11 Suppl 4:S864–S876.
-
-
Lee HW. Epidemiology and epizoology. In: Lee HW, Calisher C, Schmaljohn C, editors. Manual of Hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Seoul: ASAN Institute for Life Sciences; 1999. pp. 39.
-
-
Lednicky JA. Hantaviruses. a short review. Arch Pathol Lab Med 2003;127:30–35.
-
-
Baek LJ, Kariwa H, Lokugamage K, Yoshimatsu K, Arikawa J, Takashima I, Kang JI, Moon SS, Chung SY, Kim EJ, Kang HJ, Song KJ, Klein TA, Yanagihara R, Song JW. Soochong virus: an antigenically and genetically distinct hantavirus isolated from Apodemus peninsulae in Korea. J Med Virol 2006;78:290–297.
-
-
Van Epps HL, Schmaljohn CS, Ennis FA. Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. J Virol 1999;73:5301–5308.
-
-
Lee EJ, Kim YS, Kwon HM, Kwon YJ, Cho WY, Kim HK, Won NH. Clinical significance of renal biopsy in hemorrhagic fever with renal syndrome. Korean J Med 1991;40:642–652.
-
-
Mäkelä S, Mustonen J, Ala-Houhala I, Hurme M, Partanen J, Vapalahti O, Vaheri A, Pasternack A. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha (-308) G/A polymorphism. J Infect Dis 2002;186:843–846.
-
-
Hujakka H, Koistinen V, Kuronen I, Eerikäinen P, Parviainen M, Lundkvist A, Vaheri A, Vapalahti O, Närvänen A. Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test. J Virol Methods 2003;108:117–122.
-
-
Woo HJ, Cheong HJ, Kim WJ, Kim MJ, Park SC, Baek LJ. Diagnosis of acute Hantaan virus infection by IgG avidity assay. Korean J Med 1999;56:629–635.
-
-
Nam JH, Yu CH, Hwang KA, Ju YR. Real-time rt-PCR of hantaan virus RNA used for the detection of virus response to antiviral drugs. Acta Virol 2008;52:67–70.
-
-
Huggins JW, Hsiang CM, Cosgriff TM, Guang MY, Smith JI, Wu ZO, LeDuc JW, Zheng ZM, Meegan JM, Wang QN, Oland DD, Gui XE, Gibbs PH, Yuan GH, Zhzng TM. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991;164:1119–1127.
-
-
Lee CH, Byun KS, Kim WJ, Woo YD, Lee HW. Persistence of antibodies after immunization with the inactivated vaccine against hemorrhagic fever with renal syndrome in humans. J Korean Soc Virol 1992;22:239–243.
-
-
The Korean Society of Infectious Diseases. Vaccination for adults. Seoul: Koonja Publishing Co.; 2007.
-
-
Woo YD, Chu YK, Baek LJ, Lee HW. An immunoserological study of vaccine against haemorrhagic fever with renal syndrome. J Korean Soc Virol 2000;30:11–18.
-
-
Chu YK, Woo YD, Lee HW. Immune response and antibody persistence against Hantaan virus of vaccinees with Hantavax™. Korean J Infect Dis 1998;30:317–324.
-
-
Chu YK, Gligic A, Tomanovic S, Bozovjc B, Obradovic M, Woo YD, An CN, Kim H, Jiang YS, Park SC, Kim MJ, Lee EI, Lee HW. A field efficacy trial of inactivated Hantaan virus vaccine (Hantavax™) against hemorrhagic Fever with Renal Syndrome (HFRS) in the Endemic Areas of Yugoslavia from 1996 to 1998. J Korean Soc Virol 1999;29:55–64.
-